Answers are grounded in this paper and cite their sources.
Narrative review reveals shared HLA-B*27 pathogenesis across pediatric and adult spondyloarthritis despite clinical divergence, suggesting unified opportunities for future therapies.
HLA-B*27-associated arthritis comprises a number of different forms of inflammatory arthritis with a common phenotype, encompassed by the term spondyloarthritis. The clinical features and outcomes differ across the age spectrum which has resulted in different classification systems being applied to paediatric and adult disease. However, the pathogenesis of spondyloarthritis related to HLA-B*27 appears similar across the ages and recent advances in our understanding of the role of HLA-B*27 in the pathogenesis of spondyloarthritis may influence future treatment options.
No takes yet. Share an insight, caveat, or question.
Fisher et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: